MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC

Position in ROIV — Roivant Sciences Ltd.

CIK 922127 New York, NY

Position in ROIV

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$5,937,061

+$1,150,695 QoQ

Shares Held

167,761

-2.9% QoQ

Ownership

0.023%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#131

of 494 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC holds $184,059,662 across 45 Biotechnology names. ROIV ranks #10 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARWR	Arrowhead Pharmaceuticals, Inc.	191,432	$15,603,622
2	VRTX	Vertex Pharmaceuticals Inc / Ma	26,109	$12,969,123
3	KRYS	Krystal Biotech, Inc.	31,998	$11,892,696
4	CYTK	Cytokinetics Inc	121,652	$10,363,533
5	AXSM	Axsome Therapeutics, Inc.	40,364	$9,879,896
6	MDGL	Madrigal Pharmaceuticals, Inc.	12,418	$6,667,845
7	XENE	Xenon Pharmaceuticals Inc.	109,603	$6,615,637
8	VCEL	Vericel Corp	145,445	$6,470,848

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,937,061	167,761	-2.9%	Shares	Sole	2026-08-11
2026-03-31	$4,786,366	172,793	-5.2%	Shares	Sole	2026-05-07
2025-12-31	$3,956,995	182,350	-8.2%	Shares	Sole	2026-02-10
2025-09-30	$3,006,104	198,685	-5.1%	Shares	Sole	2025-10-31
2025-06-30	$2,359,521	209,363	-3.4%	Shares	Sole	2025-07-29
2025-03-31	$2,186,301	216,680	-39.6%	Shares	Sole	2025-05-09
2024-12-31	$4,244,828	358,819	-2.5%	Shares	Sole	2025-02-05
2024-09-30	$4,245,173	367,866	+12.5%	Shares	Sole	2024-11-06
2024-06-30	$3,457,225	327,079	+0.4%	Shares	Sole	2024-08-09
2024-03-31	$3,435,375	325,937	+116.8%	Shares	Sole	2024-05-02
2023-12-31	$1,688,576	150,363	+23.4%	Shares	Sole	2024-01-26
2023-09-30	$1,423,313	121,859	-3.9%	Shares	Sole	2023-11-09
2023-06-30	$1,278,829	126,868	—	Shares	Sole	2023-08-11
No filing history on record for this holder in this stock.